A single bolus of high dose levothyroxine (L-T4) as a test in cases of suspected poor compliance to L-T4 therapy
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Though compliance (or adherence) problems, as well as inappropriate levothyroxine (L-T4) intake (e.g. with meal, other drugs or certain foods that can significantly affect absorption) are very common, the issue is often either not mentioned or even frankly denied by patients. CASE PRESENTATION: We describe three cases of patients who presented with high TSH (ranging from about 30 to 200 mIU/l), with concomitantly either high, normal or low free thyroxine (FT4), despite treatment with high doses of L-T4. The above mentioned problems with adjustment of L-T4 dose persisted for several months or even years. Coeliac disease screen was negative in all cases. In all these patients administration of a single bolus of L-T4 (1000 μg) or two doses of 1000 μg of L-T4 within 48 h resulted in a quick increase in FT4 (thus confirming proper absorption) and in normalization of TSH within a week. No adverse effects of administration of these high doses of L-T4 were observed. CONCLUSIONS: Our data support the efficacy, as well as safety of administration of single bolus of high dose L-T4 as a test for possible compliance/adherence problems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“So far, the levothyroxine absorption test is not standardized [7-18], and multiple protocols have been published with differences regarding the test dose, formulations, test durations, frequency of blood collections, analyte (total T4, free T4), metric (absolute or relative peak or increment), and thresholds for normal absorption.”
From Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With “Refractory Hypothyroidism” (2025) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Timing of levothyroxine administration affects serum thyrotropin concentration
Bach-Huynh, T.-G., Nayak, B., Loh, J., Soldin, S., & Jonklaas, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0860 · Cited by 198 · cited 1×
“[9] demonstrated that even with full compliance, an ingestion of L-T4 tablets within 20 min of breakfast results in more than 100 % increase in mean TSH concentrations (1.”
BackgroundA review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism
Colucci, P., Yue, C. S., Ducharme, M., Benvenga, S., Principal Scientist, L. A. C. I., Principal Scientist, L. A. C. I. A. P. C., President and CEO, L. A. C. I., & Professor of Medicine, D. (2010) · European Endocrinology · doi:10.17925/ee.2013.09.01.40 · Cited by 167 · cited 2×
“guidelines require that supra-therapeutic doses of L-T4 (around 600 μg) should be administered in studies aiming to assess pharmacokinetics of L-T4 preparations [8].”
BackgroundAspects of the absorption of oral L-thyroxine in normal man
Wenzel, K. W., & Kirschsieper, H. E. (1977) · Metabolism · doi:10.1016/0026-0495(77)90121-4 · Cited by 151 · cited 3×
“Though in a seminal study of Wenzel and Kirschsieper [10] ingestion of L-T4 was reduced down to 64 % (for a 100 μg dose), if taken with food, even lower values (down to 40”
BackgroundIsmail, A. A., Walker, P. L., Barth, J. H., Lewandowski, K. C., Jones, R., & Burr, W. A. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.11.2023 · Cited by 151
Self-citationTsai, W., Pei, D., Wang, T., Wu, D., Li, J., Wei, C. L., Lee, C., Chen, S., & Kuo, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02249.x · Cited by 83
Adjunctive cholestyramine therapy for thyrotoxicosis*
Solomon, B. L., Wartofsky, L., & Burman, K. D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00970.x · Cited by 83
Treatment of Hypothyroidism with Once Weekly Thyroxine1
Grebe, S. K. G., Cooke, R. R., Ford, H. C., Fagerström, J. N., Cordwell, D. P., Lever, N. A., Purdie, G. L., & Feek, C. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3830 · Cited by 79
Absorption of Levothyroxine When Coadministered with Various Calcium Formulations
Zamfirescu, I., & Carlson, H. E. (2011) · Thyroid · doi:10.1089/thy.2010.0296 · Cited by 76
Walker, J. N., Shillo, P., Ibbotson, V, Vincent, A., Karavitaki, N., Weetman, A. P., Wass, J. A. H., & Allahabadia, A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1035 · Cited by 70
Levothyroxine absorption in health and disease, and new therapeutic perspectives.
Ianiro, G., Mangiola, F., Rienzo, T. A. D., Bibbò, S., Franceschi, F., Greco, A. V., & Gasbarrini, A. (2014) · PubMed · Cited by 69
Research works printed but not linked: 2
- Grebe SKG, Cooke RR, Ford HC, Fagerstrom JN, Cordwell DP, Lever NA, et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab. 1997;82:870–5.
- Elmahi E, Vas P, Oyibo S. Levothyroxine absorption test: a 5-day (usual dose) as an alternative to to the 1-day (1000 μg) test. Endocrine Abstr. 2013;31:P372.
Cited by
Levothyroxine absorption test to differentiate pseudomalabsorption from true malabsorption
Ghosh, S., Pramanik, S., Biswas, K., Bhattacharjee, K., Sarkar, R., Chowdhury, S., & Mukhopadhyay, P. (2020) · European Thyroid Journal · doi:10.1159/000504218 · Cited by 39
Lieder, H. R., Braczko, F., Gedik, N., Stroetges, M., Heusch, G., & Kleinbongard, P. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00868-6 · Cited by 31
Nakano, Y., Hashimoto, K., Ohkiba, N., Okuma, H., Minami, I., Takahashi, H., Tanaka, Y., Yoshimoto, T., & Yamada, T. (2019) · Case Reports in Endocrinology · doi:10.1155/2019/5986014 · Cited by 17
Caron, P., Tudor, C., & Grunenwald, S. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf017 · Cited by 8
Alba, P., Mitre, N., & Feldt, M. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0382 · Cited by 8
Metadata
- Authors
- Lewandowski, K. C., Dąbrowska, K., Komorowska-Dudek, I., & Lewiński, A.
- Affiliations
- Medical University of Lodz (PL)
- Venue
- Thyroid Research
- Published
- 2015-12
- Volume
- 8
- Issue
- 1
- Pages
- 16-16
- ISSN
- 1756-6614 (ISSN-L)
- PMC
- PMC4665860
- OpenAlex
- W2187105468
- Cited by
- 10
- References
- 16
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2016: 2
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Thyroid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- levothyroxine, medication adherence, thyroid-stimulating hormone, free thyroxine, hypothyroidism, drug absorption, hyperthyroidism, thyroid function tests
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A single bolus of high dose levothyroxine (L-T4) as a test in cases of suspected poor compliance to L-T4 therapy. https://app.cochat.ai/papers/10.1186/s13044-015-0028-0
- The paper
- Lewandowski, K. C., Dąbrowska, K., Komorowska-Dudek, I., & Lewiński, A. (2015). A single bolus of high dose levothyroxine (L-T4) as a test in cases of suspected poor compliance to L-T4 therapy. Thyroid Research. https://doi.org/10.1186/s13044-015-0028-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.